Investor · 1 deal
Every published round Existing investors took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Ferronova | Series A | 17 Dec 2025 | $6m | Participant | Wholesale Investor (29 Jan 2026), Wholesale Investor (16 Jan 2026), Startup Daily (19 Dec 2025), SmartCompany, Biotech Dispatch, Uniseed, Startup Daily (17 Dec 2025), Business News Australia, biospectrumasia.com, South Australian Venture Capital Fund portfolio |
Companies Existing investors has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Ferronova | advance image-guided cancer surgery | 17 Dec 2025, Series A | 1 | 0 |
Fund closes reported for Existing investors, as distinct from the investments it has made.
Companies Existing investors has backed that another company then bought. An exit for the holding, not a deal Existing investors did.
Stories naming Existing investors. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Wholesale Investor's Steve Torso highlights Australian life sciences companies from the Emergence Preview Series, noting government grant funding, a Series A extension, venture co-investment, and a medtech company's ASX listing.
Also Wholesale Investor